Tom Butler
Vorstandsvorsitzender bei BIOMEA FUSION, INC.
Vermögen: 26 Mio $ am 31.05.2024
Aktive Positionen von Tom Butler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOMEA FUSION, INC. | Vorstandsvorsitzender | 01.08.2017 | - |
Vorsitzender | 01.08.2017 | - | |
Gründer | 01.08.2017 | - | |
Point Sur Investors LLC
Point Sur Investors LLC Investment ManagersFinance Point Sur Investors LLC provides investment advice. The private company is based in El Cerrito, CA and has subsidiaries in the United States. The company was founded in 2015 by Thomas Butler, Rainer M. Erdtmann. | Gründer | 01.01.2015 | - |
Portfolio Manager-Aktien | 01.01.2015 | - |
Karriereverlauf von Tom Butler
Ehemalige bekannte Positionen von Tom Butler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PHARMACYCLICS, INC. | Investor Relations Kontakt | 01.01.2013 | 01.01.2015 |
Ausbildung von Tom Butler
The California State University | Undergraduate Degree |
University of California, Santa Barbara | Graduate Degree |
University of California, Los Angeles | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Founder | 2 |
Chief Executive Officer | 1 |
Chairman | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOMEA FUSION, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Point Sur Investors LLC
Point Sur Investors LLC Investment ManagersFinance Point Sur Investors LLC provides investment advice. The private company is based in El Cerrito, CA and has subsidiaries in the United States. The company was founded in 2015 by Thomas Butler, Rainer M. Erdtmann. | Finance |
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
- Börse
- Insiders
- Tom Butler
- Erfahrung